(secondQuint)Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions.

 This was an open label, balanced, and randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioavailability study planned on 32 healthy, adult, human subjects under fasting conditions.

 31 subjects completed both the periods of the study.

 Both periods were separated by a washout of twelve days The study was conducted on 32 healthy, adult, human subjects under fasting conditions.

 31 subjects completed both the periods of the study.

 Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions@highlight

The objective of the study was to compare the single-dose oral bioavailability of Clarithromycin 250 mg tablets of Ranbaxy Laboratories with Biaxin 250 mg tablets of Abbott Laboratories in healthy, adult, human subjects under fasting conditions